ROBINS JASON SHAND enters OCULAR THERAPEUTIX, INC with 52.66K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/22/2026ACC: 0001104659-26-005887
Officer· Interim CFO
Since Jan 2026
52.66K
Baseline shares
100% direct
52.66K
Direct ownership
1 position
178.79K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned52.66K
Total
52.66K direct52.66K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 52.66K | Direct |
| Total | 52.66K | 52.66K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
68.19K
Shares owned
N/A
Exercise price
11.82
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
110.60K
Shares owned
N/A
Exercise price
8.12
Expiration
—
Exercise window
—
Total
Underlying
178.79K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 11.82 | — | — | 68.19K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 8.12 | — | — | 110.60K | N/A |
| Total | 178.79K | 0.00 | ||||